4DAVIES M,NEWELL JG,DERRY JM,et al.Characterization of the interaction of Zopiclone with γ-Aminobutyric acid type A receptors[J].Mol Pharmacol,2000,58 (4):756-762.
5GARY KZ,LOUIS JM,JUDY C,et al.Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia[J].Curr Med Res Opin(Newbury),2004,20(12):1979-1991.
6WAGNER J,WAGNER ML.Non-benzodiazepines for the treatment of insomnia[J].Sleep Med Rev,2000,4(6):551 -581.
7CARLSON JN,HASKEW R,WACKER J,et al.Sedative and anxiolytic effects of zopiclone's enantiomers and metabolite[J].Eur J Pharmacol,2001,415 (2-3):181-189.
8KRYSTAL AD,WALSH JK,LASKA E,et al.Sustained efficacy of eszopiclone over 6 months of nightly treatment:result of a randomized,double-blinded,placebo-controlled study in adults with chronic insomnia[J].Sleep,2003,26 (7):793-799.
9ROSENBERG R,CARON J,ROTH T,et al.An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults[J].Sleep Med,2005,6 (1):15-22.
